Drug Target Review – Issue 3 2020

Posted: 8 September 2020 | | No comments yet

This issue includes articles that explore how a next-generation genomics platform can be used for COVID-19 research, the elimination of neutralising AAV antibodies for gene therapies and a new quick and cost-effective biomarker technology for cancer diagnostics. Also in this issue are features on antibody therapeutics for COVID-19 and targets to control M. tuberculosis

DTR - Issue 3 2020

This issue includes:

    Oncology meets immunology – antibody-mediated regulation of the immune response
    Aparajita Dubey, CRAMbridge
    Exploring the intra-protein non-covalent interactions in the S1 domain of the SARS-CoV-2 S1 Spike protein
    Oscar Bastidas, University of Minnesota
    Flow cytometry in neglected tropical diseases – a focus on leishmaniasis
    Professor Paul Kaye, University of York
    Exploring new drug targets in Alzheimer’s disease
    Monika Schmidt, University of Hradec Kralove
    Sheraz Gul, Fraunhofer Institute
  • NGS
    NGS: offering a glimmer of hope in the fight against COVID-19
    Pushpanathan Muthuirulan, Harvard University
    Cocaine and the brain: identifying targets for addiction therapies
    Hannah Balfour, Drug Target Review
    Understanding the limits of synthetic biology through the origins of SARS-CoV-2
    Marc Baiget Francesch, International Journal of Molecular Sciences

The rest of this content is restricted - login or subscribe free to access

DTR Issue 3 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here